Skip to main content
. 2017 Jun 27;61(7):e00363-17. doi: 10.1128/AAC.00363-17

TABLE 4.

De novo resistance selections with elbasvir in the GT4a (ED43) replicon

Treatment (fold multiple of EC90) No. of resistant coloniesa Activity (EC90 [nM]) in pooled colonies Fold shift (relative to DMSO) Substitution(s) observedb
3 TMTCa 0.003 6 L30F, M31V, Y93H
10 144 0.017 34 L30F, L30P, M31V, N69K, Y93H
30 35 0.02 40 L30S
a

TMTC, too many to count.

b

Key amino acid substitutions deduced from population sequencing of resistant colonies are listed.